Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OptiBiotix Health ( (GB:OPTI) ) just unveiled an update.
OptiBiotix Health has sold 7.5 million shares in SkinBioTherapeutics, raising £675,000 in cash that will be applied to general working capital and is expected to extend the company’s funding runway into the first half of 2027. Following the transaction, OptiBiotix retains 5.7 million SkinBioTherapeutics shares, equivalent to 2.2% of the skincare firm’s issued share capital, reflecting a partial monetisation of its investment while maintaining exposure to the business.
The disposal strengthens OptiBiotix’s balance sheet at a time when microbiome-based health solutions are gaining wider commercial traction, potentially giving the group more flexibility to support its core product roll-out and growth strategy. By realising value from a non-core portion of its SkinBioTherapeutics stake, the company signals a pragmatic approach to capital management without fully exiting its position in the associated skincare business.
Spark’s Take on OPTI Stock
According to Spark, TipRanks’ AI Analyst, OPTI is a Neutral.
The score is weighed down primarily by persistent losses and cash burn despite strong 2024 revenue growth, and by weak technicals showing a sustained downtrend with negative momentum. A debt-free balance sheet provides some support, but valuation remains difficult to justify with negative earnings and no dividend yield provided.
To see Spark’s full report on OPTI stock, click here.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company focused on developing microbiome-modulating technologies and products to help prevent and manage human disease. Its portfolio spans prebiotic ingredients such as SlimBiome, WellBiome, SweetBiotix and Microbiome Modulators, alongside skincare interests via SkinBioTherapeutics and probiotics through ProBiotix Health, targeting fast-growing consumer healthcare markets globally.
Average Trading Volume: 430,594
Technical Sentiment Signal: Sell
Current Market Cap: £5.06M
Learn more about OPTI stock on TipRanks’ Stock Analysis page.